Top all-time · #13683
Alex Kesin
Personal blog · alexkesin.comsciencebusinesshealth
Alex Kesin's personal blog at alexkesin.com covers science, business and health. Since 2022, 5 different Hacker News readers have linked it 20 times, most often “The Day Novartis Chose Discovery”. It is still writing: the last post was on 2026-07-07, and you can follow it by feed.
Too few sampled comments (1) to say how often HN recommends it.?
Why HN links it
Linked in an HN thread on "The Hollow Men of Hims" as an essay on China and ethnostate policy. One commenter disputes its factual accuracy.
Summarised by Claude from a sample of 1 HN comments that link here. Each comment is marked recommending, critical or neutral (citing without judging); how this works.
Ruminations about biotech and drug development - one overly earnest blog post at a time.
Most-linked posts?
- The Day Novartis Chose Discovery2 people · 2 mentions · first linked 2025-08-05
- The Cowboy of Generic Drugs2 people · 2 mentions · first linked 2025-08-25
What Hacker News says?
No, it's factually not more accurate. The CCP's policies do not dictate reality, and the morally objectional ethnostate policy is both not actually the reality within China (given that about 9% of the population is not Han Chinese), and is not practiced by the majority of other nations/states in the world. Most importantly, the author of the article is not based in China, or in any other nation that has an ethnostat…
Comment linking /p/who-is-alex-kesin
on “The Hollow Men of Hims”Submitted The Hollow Men of Hims as a story · 214 points
HN discussionSubmitted The Day Novartis Chose Discovery as a story · 29 points
HN discussionSubmitted Against "Against Life Extension" as a story · 27 points
HN discussionSubmitted Mr. Secretary, Reclassify the Statin as a story · 20 points
HN discussionSubmitted How Amgen Lost the PCSK9 Patent War as a story · 17 points
HN discussionSubmitted The Cowboy of Generic Drugs as a story · 10 points
HN discussionSubmitted China's leap in pharma: slow and fast trends behind its rise as a story · 5 points
HN discussionSubmitted Narrow Leverage: How Small Strengths Create Big Power as a story · 3 points
HN discussionSubmitted Etifoxine: Is this drug a Xanax killer? as a story · 3 points
HN discussionSubmitted Would Walter White Still Cook Meth in 2025? as a story · 2 points
HN discussionSubmitted How the new FDA can turbocharge drug development as a story · 2 points
HN discussionSubmitted Etifoxine: Is this drug a Xanax killer? as a story · 2 points
HN discussionSubmitted Keeping Up with the Thiel Fellows as a story · 2 points
HN discussionSubmitted Fun with FGF21 as a story · 1 points
HN discussionSubmitted The Cowboy of Generic Drugs as a story · 1 points
HN discussionSubmitted The Day Novartis Chose Discovery as a story · 1 points
HN discussionSubmitted Biotech Life in the Software City as a story · 1 points
HN discussionSubmitted Do's and don'ts of valuing biotech companies as a story · 1 points
HN discussionSubmitted Dr. Levin and Mr. Hyde as a story · 1 points
HN discussion